ENANTA PHARMACEUTICALS, INC Accrued Income Taxes, Current
ENANTA PHARMACEUTICALS, INC (ENTA) had Accrued Income Taxes, Current of $5.86 million as of 2018-12-31, per its 10-Q filed 2019-02-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2019-11-27
- 2018-12-31: Accrued Income Taxes, Current $5.86M.
- 2018-09-30: Accrued Income Taxes, Current $1.39M.
- 2018-03-31: Accrued Income Taxes, Current $5.38M.
- 2017-12-31: Accrued Income Taxes, Current $10.26M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2018-12-31 | $5.86M 10-Q · filed 2019-02-08 |
| 2018-09-30 | $1.39M 10-K · filed 2019-11-27 |
| 2018-03-31 | $5.38M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $10.26M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $9.30M 10-K · filed 2018-11-29 |
| 2016-06-30 | $2.94M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $6.78M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.94M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $1.20M 10-K · filed 2016-12-09 |
| 2015-06-30 | $2.23M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $14.54M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $16.90M 10-Q · filed 2015-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |